Medistus

Why choose
Medistus® Antivirus lozenges?

Medistus® Antivirus is a Class IIa medical device product (CE 0482) with Kistosyn® 200 extract. The lozenges are used for the prevention of infectious and inflammatory respiratory diseases of viral and bacterial origin by physical (mechanical) barrier formation on the oral and pharyngeal mucosa.

The Kistosyn® 200 extract contained in Medistus® Antivirus lozenges forms through its natural active substances a protective film over the oral and pharyngeal mucosa. This protective barrier leads to a physical (mechanical) protection against viruses and bacteria causing respiratory infections, which helps prevent their penetration into body cells and their further propagation.

Medistus

Natural health protection in case of infection risk

Recommended use on places with high risk of infection

Travel
Public transportation
Education
Waiting rooms
Event
Shopping

PRODUCTS

Medistus

Medistus® Antivirus

Lozenges with Kistosyn® 200 extract, in fresh fruity taste

Medistus® Antivirus is a Class IIa medical device product (CE0482) with Kistosyn® 200 extract. 
Read more
Medistus

Medistus® Antivirus Honey& Lemon

Lozenges with Kistosyn® 200 extract, in honey & lemon taste

Medistus® Antivirus is a Class IIa medical device product (CE0482) with Kistosyn® 200 extract. 
Read more

INFECTION PREVENTION

Respiratory infections
(colds)

A common cold is usually a virus-induced, acute infection of the upper respiratory tract. This type of respiratory infections is among the most common diseases in modern industrial countries. On the average adults suffer up to five times a year a cold, pre-schoolers even eight to ten times. In most cases the infections are caused by viruses and associated with similar symptoms: shivering, sneezing, runny nose, cough and fatigue. Since antibiotics work only in the treatment of bacterial infections, applying them in case of infections of viral origin, they might remain ineffective.

Infection risks
(pandemics)

Recently, infections by emerging viruses occur more frequently and they seem to be independent of seasons. These infections manifest themselves as fever from 38 °C and with symptoms such as sore throat, runny nose, cough, muscle and joint pains, headache and diarrhea.
Real influenza has to be dealt with separately from the other respiratory diseases related to cold. This infection is a disease caused by various types of influenza viruses and differs from other respiratory diseases both in its epidemiological, clinical characteristics and also in its impacts.

Penetration of viruses and bacteria in the body

Infections of the upper respiratory tract caused by viruses or bacteria will not necessarily lead to illness if the immune system is capable of effective defense against pathogens, or the pathogens are hindered at intruding the body by a barrier.
The main goal of a virus is to safeguard its own propagation for which it requires a host cell. To this end, it targets the cells in the oral mucosa and attempts to dock to them. In case of a successful attachment it penetrates the host cell membrane and reprograms it to promote its own multiplication.

Active defense
against infection

The research of the last decades has unambiguously demonstrated that in case of infection pathogens (viruses, bacteria) dock to the carbohydrate structures of the host cell membranes through their proteins based on the so-called key-lock principle. This process occurs in the oral and pharyngeal mucous membranes. In the event this docking process is successful, like a key opening a lock the pathogens penetrate the host cell and commence to multiply. The solution is compelling: we have to impede pathogens in docking to the host cells.

Read more

Medistus® Antivirus lozenges

  • act as a protective film
  • form a natural barrier
  • assist preventively
More information

PROFESSIONAL INFORMATION

Medistus® Antivirus lozenges are a Class IIa medical device product (CE 0482) with Kistosyn® 200 extract.
For the prevention of infectious and inflammatory respiratory diseases of viral and bacterial origin by physical (mechanical) barrier formation on the oral and pharyngeal mucosa.
For adults, adolescents and children from 6 years old.
Without preservatives and colorants, sugar-free, gluten-free and lactose-free.

AREAS OF APPLICATION:

  • To support by physical means the natural barrier function of the oral and pharyngeal mucosa by forming a protective film on it.
  • For the prevention of infectious and inflammatory respiratory diseases of viral and bacterial origin by physical (mechanical) barrier formation on the oral and pharyngeal mucosa.
Read more

INTRODUCTION

The production of Medistus® Antivirus lozenges takes place according to DIN EN ISO and GMP standards at the production site of a highly recognized pharmaceutical manufacturer in Germany using strictly controlled natural substances.

The license holder and the owner of the technical documentation of Medistus® Antivirus lozenges is the Innopharm GmbH in Austria.
The main activity of the company encompasses the trading and distribution of medical devices.
The Innopharm GmbH provides all necessary clinical studies and laboratory tests which are essential for the safety and efficacy of its medical devices. Furthermore, the Innopharm GmbH is the head of product development and innovation.

The exclusive rights for worldwide distribution are conferred upon the Vitaplus Kft in Hungary owing to its long-term experience and extensive network of commercial partners.
Medistus® Antivirus was introduced by Vitaplus Kft in numerous countries in Europe and has successfully been distributed there ever since.

Link to: Fertőzésmegelőzés


Learn
more!

Link to: Szakmai információk

Clinical
and medical
information